India launches 1st indigenous CRISPR-based gene therapy for Sickle Cell Disease
New Delhi, Nov 19 (IANS) Setting a new milestone in Atmanirbhar Bharat, the government on Wednesday launched an indigenous CRISPR-based gene therapy for Sickle Cell Disease, which particularly affects India's tribal population.The world-class, low-cost gene editing solution named "BIRSA 101", in honour of Bhagwan Birsa Munda, remembered as a great…
Read More...